GridAI Technologies Corp. Common Stock GRDX
Key Stats
- Today's Range
- $3.55 – $5.79
- 50-Day Range
- $2.75 – $6.00
- 52-Week Range
- $1.87 – $6.93
- Volume
- 504K shs
- Average Volume
- 122K shs
- Market Cap
- $48.18 million
- P/E Ratio
- —
- Dividend Yield
- —
About GridAI Technologies Corp. Common Stock
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Related Stocks
Compare head-to-head: GRDX vs XEL·GRDX vs EXC·GRDX vs AEE·GRDX vs PCG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.